Leserbrief
Treatment Escalation and Risk Factors for Intrapleural Enzymatic Therapy Failure
CHEST · 2026-06 · 169 (6) · e200-e201
DOI: 10.1016/j.chest.2026.01.010 ↗Kurz gefasst
Leserbrief in der Zeitschrift CHEST, 2026-06. Verfasst von Leela Krishna Teja Boppana und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Rochester Medical Center, Rochester, NY. Electronic address: lktboppana@gmail.com. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- University of Rochester Medical Center, Rochester, NY. Electronic address: lktboppana@gmail.com.
- Division of Pulmonary, Critical Care and Sleep Medicine, University of Florida Health, Gainesville, FL.
Zitieren
APA
Boppana, L. K. T., & Mehta, H. J. (2026). Treatment Escalation and Risk Factors for Intrapleural Enzymatic Therapy Failure. CHEST, 169(6), e200-e201. https://doi.org/10.1016/j.chest.2026.01.010
Vancouver
Boppana LKT, Mehta HJ. Treatment Escalation and Risk Factors for Intrapleural Enzymatic Therapy Failure. CHEST. 2026;169(6):e200-e201. doi:10.1016/j.chest.2026.01.010
BibTeX
@article{Boppana2026,
author = {Boppana, Leela Krishna Teja and Mehta, Hiren J},
title = {Treatment Escalation and Risk Factors for Intrapleural Enzymatic Therapy Failure},
journal = {CHEST},
year = {2026},
volume = {169},
number = {6},
pages = {e200--e201},
doi = {10.1016/j.chest.2026.01.010}
}
EUVIMED